Link to this page
Physician Data Query
| Preferred Name | tazarotene | |
| Synonyms |
Stieva-A AGN-190168 Avage Ethyl 6-(2-(4,4-Dimethylthiochroman-6-yl)ethynyl)nicotinate Vitinoin 6-[(3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]- 3-Pyridinecarboxylic Acid, Ethyl Ester Tazorac Stieva-A Forte Retisol-A |
|
| Definitions |
A synthetic, topical retinoid. Tazarotene induces the expression of tazarotene-induced gene 3 (TIG3), a tumor suppressor gene. In psoriasis, tazarotene normalizes abnormal keratinocyte differentiation and reduces their hyperproliferation. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C29487" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C29487" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000553530 |
|
| altLabel |
Stieva-A AGN-190168 Avage Ethyl 6-(2-(4,4-Dimethylthiochroman-6-yl)ethynyl)nicotinate Vitinoin 6-[(3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]- 3-Pyridinecarboxylic Acid, Ethyl Ester Tazorac Stieva-A Forte Retisol-A
|
|
| CAS Registry |
118292-40-3
|
|
| cui |
C1520055 C1170075 C1515230 C0253908 C1520056 C1520057 C0723607 C0288792
|
|
| DATE FIRST PUBLISHED |
2007-06-08
|
|
| definition |
A synthetic, topical retinoid. Tazarotene induces the expression of tazarotene-induced gene 3 (TIG3), a tumor suppressor gene. In psoriasis, tazarotene normalizes abnormal keratinocyte differentiation and reduces their hyperproliferation. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C29487" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C29487" NCI Thesaurus)
|
|
| LT |
TRD
|
|
| NCI ID |
C29487
|
|
| notation |
CDR0000553530
|
|
| ORIG STY |
Drug/agent
|
|
| prefLabel |
tazarotene
|
|
| tui |
T109 T121
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |